Stock Down Under

Money-Making Insights On

ASX-Listed Stocks

Recent Articles

Find Us in

Stocks Down Under Analysts delve into a large variety of ASX-listed stocks and sectors.

AMP (ASX:AMP): It is up 50% since November 2023! Is a better future ahead?

By Nick Sundich | October 16, 2024

One time wealth management giant AMP (ASX: AMP) has endured a massive fall from grace over the years. There is an argument to be made that now is turnaround time, since it now has a banking brand and wealth management platform, which are both performing well. And shares are up over 50% since November last…

Read More

Here are 5 companies that use an October to September financial year, and are reporting FY24 results soon

By Nick Sundich | October 16, 2024

If you thought reporting season was done and dusted for all companies, you’d be wrong – because some companies use an October to September financial year. And these companies will be reporting in the next few weeks. Most use a July to June financial year, but can use whatever 12 month period they like as…

Read More

Island Pharmaceuticals (ASX:ILA): One of the rare ASX biotechs fighting mosquito diseases – and its in Phase 2

By Nick Sundich | October 15, 2024

Island Pharmaceuticals (ASX:ILA) is one of the few (if not the only) ASX-listed Biotechs that is focused on mosquito diseases, primarily Dengue fever. Mosquito diseases, such as Dengue, are expensive to treat and are expected to proliferate due to climate change and the consequential boom in the mosquito population. But maybe Island Pharmaceuticals can help.…

Read More

Here’s why you’ll see more ASX biotechs focus on Asia in the years ahead!

By Nick Sundich | October 15, 2024

Investors should expect to see more ASX biotechs focus on Asia in the years ahead. And there are good reasons why. For many companies, the golden market has been the USA, given its population and stringent regulator the Food and Drug Administration (FDA). If a company can commercialise a drug in the USA, it can…

Read More

Blinklab (ASX:BB1): Is this exciting company the next ResApp?

By Nick Sundich | October 14, 2024

Blinklab (ASX:BB1), the conclusion to the response to a question of how you could help children with autism – a response that begins with ‘there’s an app for that’. There is precedent for app-based health companies to succeed, just look at ResApp (ASX:RAP) which was bought by Pfizer for $179m back in 2022. The former…

Read More

Here are 5 useful ways other than NPAT to measure a company’s performance

By Nick Sundich | October 14, 2024

How can you judge measure a company’s performance other than through NPAT? NPAT (Net Profit After Tax) is a useful guide but it should not be the sole measure of judging a company’s performance. After all, it does not take into account other significant factors, such as investments made in the business, changes in market conditions,…

Read More

Which Stocks Are Impacted by the Rising Oil Prices as Israel and Iran Fight It Out?

By Ujjwal Maheshwari | October 11, 2024

The long-standing conflict between Israel and Iran has some deep-rooted political and regional aspects with tensions jumping back decades. One of the key issues that is equally confusing is Israel’s existence as a Jewish state, which Iran (an Islamic nation since around 1979) has not recognized. The conflict potentially intensified when Iran extended its support…

Read More

Why Interest Rates May Start Coming Down in November in Australia

By Ujjwal Maheshwari | October 11, 2024

Interest rate is the cost of borrowing money. But it can also be defined as the reward for saving money over some time. Take an example of a mortgage or credit card. The original amount borrowed must be paid back, excluding a certain percentage of the loan amount as interest. So, typically interest rates can…

Read More

Highfield Resources (ASX:HFR) finally makes it to the big time

By Stuart Roberts | October 11, 2024

Highfield Resources could be a Unicorn in the making It was a long time in coming. Highfield Resources (ASX:HFR) started working on its Muga Potash Project in northern Spain in 2012. However, it has only been in the last 3 years that the project has got fully permitted, funded and ready for construction. Last month…

Read More

So your company announced a non-binding MOU: Is it a genuine deal or desperate puffery?

By Nick Sundich | October 11, 2024

When you’re invested in a microcap stock, you might hear it has signed a ‘non-binding MOU’ (short for Memorandum of Understanding). It is said that the journey of a thousand miles begins with the first step. Are they the first step of a long journey, or just desperate puffery?   What is a ‘non-binding MOU’?…

Read More

Sector Analysis

The-Best-Mining-Stocks

The Best Mining Stocks

Mining and resources stocks have substantial potential given demand for all types of resources and metals from gold and iron ore to battery metals like lithium and graphite! There are over 700 stocks in this sector from big miners to small cap explorers.

The-Best-Tech-Stocks

The Best Tech Stocks

Tech stocks are appetising in the context of an increasingly digital world ranging from data centre builders, cloud services providers and cybersecurity companies. Many of the ASX's best performing stocks in the last decade have been tech stocks.

The-Best-Uranium-Stocks

The Best Uranium Stocks

Uranium stocks are in a good spot right now with rising demand for clean energy, nuclear energy making a comeback and yellowcake pricing reaching levels not seen since the GFC. This has enabled many companies with mothballed projects to bring them out of hibernation.

Untitled design

The Best Healthcare Stocks

There are dozens of Healthcare stocks on the ASX ranging from big names like CSL and Cochlear with established products and markets, to small cap biotechs and medtechs hoping to follow in their footsteps and commercialise the next big innovation.

The-Best-Mining-Stocks

The Best Mining Stocks

The-Best-Tech-Stocks

The Best Tech Stocks

The-Best-Uranium-Stocks

The Best Uranium Stocks

Share Type Analysis

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The quest for the best stocks to buy now is a never-ending one, but armed with a solid investment strategy, you can create a diversified portfolio that stands the test of time. We provide our Top 10 ASX stocks we think investors should consider right now. 

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The Top Penny Stocks

The Top Penny Stocks

Navigating ASX Penny stocks, can be complex, given the diversity of companies operating in various sectors and the high risk associated with them. But there is potential for impressive returns if investors can find the right company.

The Top Penny Stocks

The Top Penny Stocks

The Top Dividend Stocks

The Top Dividend Stocks

Investing in Dividend stocks can provide an additional source of income, and so are popular with a wide variety of investors. But only some companies pay dividends, and even consistent payers can fluctuate payouts year to year. We outline the Top Dividend Stocks for investors to consider.

The Top Dividend Stocks

The Top Dividend Stocks

size set 1

Top ASX Index Funds

Explore our comprehensive analysis of the top ASX index funds, carefully curated by industry experts. Discover which funds are currently outperforming and why, based on detailed market trends and performance metrics. Ideal for both new and seasoned investors seeking strategic investment opportunities on the ASX. Dive into our report today to make informed investment decisions.

size set 1

Top ASX Index Funds

size 2

The Top Blue Chip Stocks

Discover the best ASX blue chip stocks for investment. Our industry experts provide in-depth analysis on these well-established companies with strong credit ratings and a long history of performance and stability. Explore market leaders like Commonwealth Bank of Australia, BHP Group Ltd, and National Australia Bank Limited.

size 2

The Top Blue Chip Stocks

size 3

Top ASX Growth Stocks for Investing

Explore our comprehensive analysis of the top ASX growth stocks for investing. Our industry experts have curated a detailed report on the most promising opportunities available in the market. Whether you're a seasoned investor or just starting out, our insights provide valuable information to help you make informed decisions.

size 3

Top ASX Growth Stocks for Investing

Webinars and Interviews

Rhythm Biosciences (ASX: RHY): Interview with CEO David Atkins

Rhythm Biosciences (ASX:RHY) We spoke to Dr. David Atkins, CEO of Rhythm Biosciences (ASX: RHY), about…

AFT Pharmaceuticals (ASX:AFP) at the Pitt Street Research Life Sciences Conference 2024

AFT Pharmaceuticals (ASX:AFP) AFT Pharmaceuticals (ASX:AFP) CEO Dr. Harley Atkinson presented at the Pitt Street Research…

Island Pharmaceuticals (ASX:ILA) spoke at the Pitt Street Research Life Sciences Conference 2024

Island Pharmaceuticals (ASX:ILA) Island Pharmaceuticals (ASX:ILA) Executive Chairman Dr. Paul MacLeman spoke at the Pitt Street…

Cann Group (ASX:CAN) at the Pitt Street Research Life Sciences Conference 2024

Cann Group (ASX:CAN) Cann Group (ASX:CAN) Jenni Pilcher spoke at the Pitt Street Research Life Sciences…

Investment Glossary

Small Cap Company

What Is a Small Cap Company? A Complete Guide for Investors

September 24, 2024

Overview of Small Cap Companies…

All Ordinaries Index

What is the All Ordinaries Index and How Does It Work?

September 20, 2024

The All Ordinaries Index, also…

What is Commodity?

What is Commodity? Understanding Commodity Trading

May 23, 2024

Introduction to Commodities Commodities are…

Securities

Overview of Securities in the Australian Financial Market

May 23, 2024

What is a security? Security refers…

IPO

What Is an IPO? Understanding Initial Public Offerings

May 23, 2024

What is IPO? An Initial Public…

The Team Behind Stocks Down Under

1rw

Stuart Roberts

Co-Founder

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research

Marc-circle-300x300_webp

Marc Kennis

Co-Founder

Marc is the co-founder of Stocks Down Under and has 25+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research,

The Team Behind Stocks Down Under

STUART ROBERTS

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research together with Marc.

MARC KENNIS

Marc is the co-founder of Stocks Down Under and has 20+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research, Australia's preeminent issuer-sponsored equities research firm.

PETER KILBY

Pete is Stocks Down Under's head of customer service. He is an avid investor with a knack for deep-dive company research. Pete likes the more established companies on ASX, but doesn't shy away from the occasional risky play. At Stocks Down Under he gets to do the two things he loves most, investing and talking to like-minded people.

Please enter your name.
Please enter a message.